Integrated Preclinical Imaging
From high content cellular imaging to in vivo bioluminescent models and spatial biology, Crown Bioscience delivers imaging technologies that connect mechanism, response, and translation across drug discovery and development.
Imaging Across Biological Scales
Our imaging technologies span cells, tissues, and in vivo models, enabling quantitative insight from early discovery through translational research.
Automated, multiparametric high content imaging enables quantitative assessment of cellular phenotypes, target engagement, and mechanism of action across 2D and 3D in vitro models, supporting scalable screening and hypothesis driven studies.
Orthotopic and bioluminescent tumor models enable non-invasive, longitudinal monitoring of tumor growth, metastasis, and treatment response, providing clinically relevant insight into disease progression and therapeutic efficacy.
Integrated spatial biology and digital pathology workflows preserve tissue context while enabling high-resolution molecular and histological analysis, supporting biomarker discovery, mechanism of action, and translational insight.
Ready to De-risk Your Next Candidate?
Partner with Crown Bioscience's Integrated Preclinical Imaging scientists to design an efficient, regulatory-focused strategy for your drug discovery program.
